Psychiatry & Neurology Doctors in Southampton, PA Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Dr. Peter Frederick Finelli, D.O. Psychiatry & Neurology - Addiction Medicine Medicare: Not Enrolled in Medicare Practice Location: 506 Lakeside Dr., Southampton, PA 18966 Phone: 215-364-1400

Dr. Jeffrey Alan Herman, D.O. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 506 Lakeside Drive, Southampton, PA 18966 Phone: 215-364-1400    Fax: 215-357-4495

Razvan S Tornea, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1111 Street Rd, Suite 312, Southampton, PA 18966 Phone: 215-355-2011    Fax: 215-396-1886

Kathleen Schramm, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1111 Street Rd, Suite 312, Southampton, PA 18966 Phone: 215-355-2011    Fax: 215-396-1883

Hyung Yeo, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 928 Jaymor Rd, Suite B150, Southampton, PA 18966 Phone: 215-947-8654    Fax: 215-938-7607

News Archive

Health care system has reached a breaking point: HHS Secretary

Health and Human Services Secretary Kathleen Sebelius today released a new state by state analysis of last week's U.S. Census numbers regarding the uninsured. The results are sobering and confirm that health insurance reform cannot wait another year.

Latina, Vietnamese women turn to many sources for information about the HPV vaccine, study reveals

Latina and Vietnamese women are disproportionately impacted by cervical cancer-causing human papillomavirus (HPV), a common but preventable viral infection of the reproductive tract.

Anadys Pharmaceuticals reports positive 4-week results from its ANA598 Phase II study for HCV

Anadys Pharmaceuticals, Inc. today announced preliminary results from a planned interim analysis of data at four weeks for the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.

PerkinElmer expands fetal, maternal and neonatal health screening capability in India

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and their environment, today announced that it has expanded its fetal, maternal and neonatal health screening capability in India, with the inauguration of the PerkinElmer Health Sciences laboratory.

State-level Medicaid cuts could have impact beyond federal reductions

In related news, Minnesota Public Radio reports on how the well-being of rural health providers is linked to Medicaid and Medicare reimbursement.

Read more Medical News

› Verified 1 days ago